Category Archives: Proton Pump Inhibitors

Featured Stories
Cancer Groups Call for E-cigarettes Regulation/Research

Two-Leading-Cancer-Groups-Issue-Call-for-Regulation-of-E-cigarettes-and-Research-on-Health-Risks

The American Society of Clinical Oncology & the American Association for Cancer Research called for government regulation & research of e-cigarettes on health effects.

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Transvaginal Mesh a Nightmare for Thousands of Women

Thousands of women who have received transvaginal mesh surgical implants to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) are now living a nightmare, thanks to debilitating pain, bleeding, infection and other serious complications. According to the Sun-Sentinel, many of the women injured by transvaginal mesh claim ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Popular Acid Reflux Medication Nexium Linked to Kidney Issues

Acid Reflux Medication Nexium Linked to Kidney Issues

Recent revelations about Nexium have uncovered kidney side effects in one of the most frequently prescribed treatments for excess stomach acid. Nexium is the brand name for esomeprazole, manufactured by Astra Zeneca. Nexium conditions such as gastroesophageal reflux or Zollinger-Ellison … Continue reading

Posted in Nexium, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , , , , , |

Nexium, Other PPIs and the Risk of Kidney Side Effects

Nexium, Other PPIs and the Risk of Kidney Side Effects

Nexium, Prilosec and Prevacid are part of a class of medications known as proton pump inhibitors (PPIs). They are used to relieve heartburn and acid reflux by lowering the amount of acid produced by the stomach. Recent studies suggest that … Continue reading

Posted in Nexium, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , , , , , , , |

Research Suggests Long-Term PPI Use is Linked to Kidney Damage

Research Suggests Long-Term PPI Use Linked to Kidney Damage

Two studies published this year evaluated the risk of kidney damage associated with proton pump inhibitors (PPIs). PPIs, which treat heartburn and acid reflux by lowering the amount of stomach acid produced, include Prilosec, Nexium and Prevacid. The studies suggest … Continue reading

Posted in Nexium, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , , , , , , , , , , , |

Increased Dementia Risk Linked to Heartburn Drugs Linked to Use of Proton Pump Inhibitors for Heartburn

New research suggests that the use of certain drugs for gastric reflux or peptic ulcers creates an increased risk for dementia in elderly patients. The class of drugs—proton pump inhibitors (PPIs)—includes Prevacid (lansoprazole), Nexium (esomeprazole), and Prilosec (omeprazole), HealthDay reports.

Posted in Defective Products, Health Concerns, Nexium, Pharmaceuticals, Proton Pump Inhibitors |

Widely Used Heartburn Drugs Linked to Increased Risk for Dementia

Researchers say repeated use certain drugs for gastric reflux or peptic ulcers is linked to a higher risk for dementia among patients in Germany. The class of drugs—proton pump inhibitors (PPIs)—includes Prevacid (lansoprazole), manufactured by Novartis, Nexium (esomeprazole) and Prilosec … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors |

Common Heartburn Drugs May Increase Risk for Kidney Disease

Proton-pump-inhibitors

Proton pump inhibitors (PPIs)—widely used heartburn medicines—may increase the risk for kidney disease. PPIs are sold under brand names, including Nexium, Prevacid and Prilosec, in both prescription and over-the-counter formulas. Proton pump inhibitors (PPIs) greatly reduce the amount of acid … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , , , |

Study Shows Proton Pump Inhibitors May Increase Heart Attack Risk

Proton Pump Inhibitors May Increase Heart Attack Risk

  A data-mining study published on June 10 in PLOS One shows that people who take proton pump inhibitor drugs for gastroesophageal reflux disease (GERD) are at increased risk for heart attacks. The study evaluated data for 2.9 million patients … Continue reading

Posted in Health Concerns, Pharmaceuticals, Proton Pump Inhibitors | Tagged , , , |

Stomach Acid Medications May Increase Risk of Vitamin Deficiency

stomach-aid-vitamin-deficiency

Some drugs widely used to control stomach acid may increase the risk of a serious vitamin deficiency, a new study suggests. A research team found that people who were diagnosed with vitamin B12 deficiency were more likely to be taking … Continue reading

Posted in Health Concerns, Nexium, Pharmaceuticals, Proton Pump Inhibitors |

Kidney transplant rejections higher among those prescribed PPI acid-blockers

A retrospective study of kidney transplant patients found that those taking Proton Pump Inhibitor (PPI) drugs in conjunction with another drug in the year after their surgery were more likely to experience rejection. According to a report at RenalandUrologyNews.com on … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged , , |

Proton Pump Inhibitors Raise Infection Risk in Cirrhosis Patients

Proton Pump Inhibitors (PPIs) such as Prilosec, Aciphex, Prevacid, and Protonix, raise infection risks in cirrhosis patients, according to a new study that found the risk for serious infections affects patients with decompensated cirrhosis. PPI users suffer from a 66 … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.